Cord blood injection may halt dry AMD progression

NCT ID NCT06536062

Recruiting now Disease control Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 25 times

Summary

This study tests whether injecting a special solution made from umbilical cord blood and platelet-rich plasma into the eye can slow or stop the worsening of dry age-related macular degeneration (AMD), a common cause of vision loss in older adults. About 36 people aged 65 and older with dry AMD in both eyes will receive either the injection or a sham procedure. The main goal is to see if the treatment can limit the growth of damaged areas in the retina over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY AGE-RELATED MACULAR DEGENERATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITING

Rome, Rome, 00168, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

DRY AGE-RELATED MACULAR DEGENERATION